Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Acedoben

From Wikipedia, the free encyclopedia
Acedoben[1][2]
Skeletal formula
Skeletal formula
Ball-and-stick model
Ball-and-stick model
Names
Preferred IUPAC name
4-Acetamidobenzoic acid
Other names
N-Acetyl-PABA; 4-Carboxyacetanilide; p-Acetamidobenzoic acid p-Acetaminobenzoic acid; PAAB; p-Acetoaminobenzoic acid
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
DrugBank
ECHA InfoCard 100.008.287 Edit this at Wikidata
UNII
  • InChI=1S/C9H9NO3/c1-6(11)10-8-4-2-7(3-5-8)9(12)13/h2-5H,1H3,(H,10,11)(H,12,13) checkY
    Key: QCXJEYYXVJIFCE-UHFFFAOYSA-N checkY
  • InChI=1/C9H9NO3/c1-6(11)10-8-4-2-7(3-5-8)9(12)13/h2-5H,1H3,(H,10,11)(H,12,13)
    Key: QCXJEYYXVJIFCE-UHFFFAOYAT
  • InChI=1S/C9H9NO3/c1-6(11)10-8-4-2-7(3-5-8)9(12)13/h2-5H,1H3,(H,10,11)(H,12,13)
    Key: QCXJEYYXVJIFCE-UHFFFAOYSA-N
  • O=C(Nc1ccc(cc1)C(=O)O)C
  • O=C(Nc1ccc(cc1)C(=O)O)C
  • CC(=O)NC1=CC=C(C=C1)C(=O)O
Properties
C9H9NO3
Molar mass 179.175 g·mol−1
Melting point 259 to 262 °C (498 to 504 °F; 532 to 535 K) (dec.)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X markN verify (what is checkYX markN ?)

Acedoben (4-acetamidobenzoic acid or N-acetyl-PABA) is a chemical compound with the molecular formula of C9H9NO3. It is the acetyl derivative of para-aminobenzoic acid (PABA).

Acedoben, as a salt with dimepranol, is a component of some pharmaceutical preparations such as inosine pranobex.

Tacedinaline

Acedoben has application in the synthesis of a drug that is called Tacedinaline.[3]

See also

[edit]

References

[edit]
  1. "4-Acetamidobenzoic acid". Sigma-Aldrich.
  2. Acedoben, ChemIndustry.com
  3. Gediya, L. K.; Belosay, A.; Khandelwal, A.; Purushottamachar, P.; Njar, V. C. O. (March 2008). "Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts". Bioorganic & Medicinal Chemistry. 16 (6): 3352–3360. doi:10.1016/j.bmc.2007.12.007. PMC 2374748.